Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. More Details
Flawless balance sheet with reasonable growth potential.
Share Price & News
How has Advanced Medical Solutions Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AMS is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: AMS's weekly volatility (3%) has been stable over the past year.
7 Day Return
GB Medical Equipment
1 Year Return
GB Medical Equipment
Return vs Industry: AMS exceeded the UK Medical Equipment industry which returned 1.5% over the past year.
Return vs Market: AMS exceeded the UK Market which returned 21.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Advanced Medical Solutions Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StThe Advanced Medical Solutions Group (LON:AMS) Share Price Has Gained 56% And Shareholders Are Hoping For More
2 months ago | Simply Wall StSome Investors May Be Worried About Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
Is Advanced Medical Solutions Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AMS (£2.8) is trading below our estimate of fair value (£3.52)
Significantly Below Fair Value: AMS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: AMS is poor value based on its PE Ratio (70.2x) compared to the UK Medical Equipment industry average (45.1x).
PE vs Market: AMS is poor value based on its PE Ratio (70.2x) compared to the UK market (23.5x).
Price to Earnings Growth Ratio
PEG Ratio: AMS is poor value based on its PEG Ratio (2.8x)
Price to Book Ratio
PB vs Industry: AMS is good value based on its PB Ratio (3x) compared to the GB Medical Equipment industry average (3.6x).
How is Advanced Medical Solutions Group forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMS's forecast earnings growth (25% per year) is above the savings rate (0.9%).
Earnings vs Market: AMS's earnings (25% per year) are forecast to grow faster than the UK market (14.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMS's revenue (6.7% per year) is forecast to grow faster than the UK market (4.7% per year).
High Growth Revenue: AMS's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AMS's Return on Equity is forecast to be low in 3 years time (11%).
How has Advanced Medical Solutions Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AMS has high quality earnings.
Growing Profit Margin: AMS's current net profit margins (9.9%) are lower than last year (18.5%).
Past Earnings Growth Analysis
Earnings Trend: AMS's earnings have declined by 0.7% per year over the past 5 years.
Accelerating Growth: AMS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AMS had negative earnings growth (-54.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (40.8%).
Return on Equity
High ROE: AMS's Return on Equity (4.2%) is considered low.
How is Advanced Medical Solutions Group's financial position?
Financial Position Analysis
Short Term Liabilities: AMS's short term assets (£97.2M) exceed its short term liabilities (£14.7M).
Long Term Liabilities: AMS's short term assets (£97.2M) exceed its long term liabilities (£21.6M).
Debt to Equity History and Analysis
Debt Level: AMS is debt free.
Reducing Debt: AMS currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Debt Coverage: AMS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: AMS has no debt, therefore coverage of interest payments is not a concern.
What is Advanced Medical Solutions Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: AMS's dividend (0.61%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.3%).
High Dividend: AMS's dividend (0.61%) is low compared to the top 25% of dividend payers in the UK market (3.87%).
Stability and Growth of Payments
Stable Dividend: AMS is not paying a notable dividend for the UK market, therefore no need to check if payments are stable.
Growing Dividend: AMS is not paying a notable dividend for the UK market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: AMS is not paying a notable dividend for the UK market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AMS's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Chris Meredith (54 yo)
Mr. Andrew Christopher Meredith, also known as Chris, B.Sc. (Hons.) has been the Chief Executive Officer of Advanced Medical Solutions Group plc since January 2011 and served as Chief Operating Officer sin...
CEO Compensation Analysis
Compensation vs Market: Chris's total compensation ($USD746.52K) is about average for companies of similar size in the UK market ($USD973.34K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
Experienced Management: AMS's management team is considered experienced (2.8 years average tenure).
Experienced Board: AMS's board of directors are considered experienced (7.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Advanced Medical Solutions Group plc's company bio, employee growth, exchange listings and data sources
- Name: Advanced Medical Solutions Group plc
- Ticker: AMS
- Exchange: AIM
- Founded: 1991
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: UK£604.121m
- Shares outstanding: 215.76m
- Website: https://www.admedsol.com
Number of Employees
- Advanced Medical Solutions Group plc
- Premier Park
- 33 Road One
- CW7 3RT
- United Kingdom
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/08/04 21:38|
|End of Day Share Price||2021/08/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.